Enzo Biochem Inc (ENZ)
0.97
0.00 (0.00%)
USD |
NYSE |
Nov 22, 16:00
0.9553
-0.01
(-1.52%)
After-Hours: 20:00
Enzo Biochem Enterprise Value: -1.429M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | -1.429M |
| November 21, 2024 | -1.429M |
| November 20, 2024 | -0.5358M |
| November 19, 2024 | 0.6605M |
| November 18, 2024 | 1.183M |
| November 15, 2024 | 2.228M |
| November 14, 2024 | 7.452M |
| November 13, 2024 | 7.452M |
| November 12, 2024 | 8.497M |
| November 11, 2024 | 7.452M |
| November 08, 2024 | 7.975M |
| November 07, 2024 | 6.930M |
| November 06, 2024 | 6.930M |
| November 05, 2024 | 6.407M |
| November 04, 2024 | 6.930M |
| November 01, 2024 | 6.930M |
| October 31, 2024 | 7.975M |
| October 30, 2024 | 7.975M |
| October 29, 2024 | 6.930M |
| October 28, 2024 | 6.407M |
| October 25, 2024 | 7.452M |
| October 24, 2024 | 8.497M |
| October 23, 2024 | 7.452M |
| October 22, 2024 | 8.497M |
| October 21, 2024 | 7.452M |
| Date | Value |
|---|---|
| October 18, 2024 | 7.975M |
| October 17, 2024 | 6.930M |
| October 16, 2024 | 6.930M |
| October 15, 2024 | 6.930M |
| October 14, 2024 | 6.930M |
| October 11, 2024 | 7.452M |
| October 10, 2024 | 6.407M |
| October 09, 2024 | 7.452M |
| October 08, 2024 | 6.930M |
| October 07, 2024 | 6.930M |
| October 04, 2024 | 7.452M |
| October 03, 2024 | 6.930M |
| October 02, 2024 | 7.452M |
| October 01, 2024 | 5.885M |
| September 30, 2024 | 6.407M |
| September 27, 2024 | 6.930M |
| September 26, 2024 | 7.452M |
| September 25, 2024 | 6.407M |
| September 24, 2024 | 6.407M |
| September 23, 2024 | 8.497M |
| September 20, 2024 | 9.542M |
| September 19, 2024 | 7.452M |
| September 18, 2024 | 5.885M |
| September 17, 2024 | 6.407M |
| September 16, 2024 | 5.885M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-14.52M
Minimum
Sep 15 2023
163.66M
Maximum
Mar 16 2021
71.55M
Average
78.45M
Median
Jul 09 2020
Enterprise Value Benchmarks
| Delcath Systems Inc | 300.07M |
| Star Equity Holdings Inc | 33.44M |
| Exact Sciences Corp | 11.34B |
| CytoSorbents Corp | 58.43M |
| Progyny Inc | 1.079B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.38M |
| Revenue (Quarterly) | 7.526M |
| Total Expenses (Quarterly) | 12.72M |
| EPS Diluted (Quarterly) | -0.26 |
| Gross Profit Margin (Quarterly) | 42.78% |
| Profit Margin (Quarterly) | -177.8% |
| Earnings Yield | -52.58% |
| Normalized Earnings Yield | -16.83 |